Back to search

Article

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

2021-01-19

Abstract excerpt

To date severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 100 million individuals resulting in over two million deaths. Many vaccines are being deployed to prevent coronavirus disease 2019 (COVID-19) including two novel mRNA-based vaccines 1,2 . These vaccines elicit neutralizing antibodies and appear to be safe and effective, but the precise nature of the elicited antibodies is not k...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4c526d7f-f7bf-57df-a0f8-af0f67e5ea56
DOI
10.1101/2021.01.15.426911
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsDOI 10.1101/2021.01.15.426911
Select a neighboring publication to make it the new centre.